Fragile X syndrome

Last updated: November 01, 2022

Fragile X syndrome

Cardiovascular

Cardiovascular

Development of the cardiovascular system
Anatomy of the heart
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Pressures in the cardiovascular system
Hyperlipidemia
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Hereditary spherocytosis
Li-Fraumeni syndrome
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Krabbe disease
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Primary ciliary dyskinesia
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Lesch-Nyhan syndrome
Muscular dystrophy
Ornithine transcarbamylase deficiency
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Hypertension
Baroreceptors
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Lipid-lowering medications: Fibrates
Microcirculation and Starling forces
ECG basics
ECG intervals
ECG axis
ECG normal sinus rhythm
ECG QRS transition
ECG rate and rhythm
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Renin-angiotensin-aldosterone system
Myocardial infarction
Tetralogy of Fallot
Atrial septal defect
Ventricular septal defect
Thiazide and thiazide-like diuretics
Adrenergic antagonists: Beta blockers
Calcium channel blockers
ACE inhibitors, ARBs and direct renin inhibitors
Abnormal heart sounds
Normal heart sounds
Action potentials in myocytes
Excitability and refractory periods
Action potentials in pacemaker cells
Cardiac excitation-contraction coupling
Cardiac conduction velocity
Cardiac conduction system
Persistent truncus arteriosus
Atrial fibrillation
Ventricular tachycardia
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart failure
Long QT syndrome and Torsade de pointes
Aortic valve disease
Mitral valve disease
Loop diuretics
Peripheral artery disease

Transcript

Watch video only

With Fragile X syndrome, sometimes just called Fragile X, the “X” refers to the X chromosome, where the disease gene is located.

The “fragile” refers to the fact that under a microscope, the X chromosome looks fragile or broken at the site of the mutation.

That’s because the chromatin which makes up the chromosome gets really condensed at that point.

Fragile X is a genetic disease that affects various organ systems.

Now, the gene for Fragile X is called FMR1, which stands for Fragile X mental retardation 1.

Mental retardation is the old term for intellectual disability, which is one of the key features of Fragile X syndrome.

The FMR1 gene has a triplet repeat, or trinucleotide repeat, which means that a group of three DNA nucleotides is repeated multiple times in a row.

In FMR1, it’s the nucleotides cytosine, guanine, and guanine, or CGG.

These CGGs are found in the 5’ untranslated region of FMR1.

A 5’ untranslated region is the part of DNA at the beginning of the gene that’s made into mRNA but not protein, and helps modulate gene expression.

Just upstream from the 5’ untranslated region is FMR1‘s promoter, the region that causes the gene to be transcribed to mRNA, which is usually turned on.

Expressed FMR1 mRNA gets translated into Fragile X mental retardation protein, or FMRP, and it helps in development of the brain and other tissues.

In Fragile X syndrome, there is a repeat expansion, meaning there’s an increased number of CGG repeats in the gene.

This repeat expansion is caused by slipped mispairing, which is where the enzyme DNA polymerase gets confused when copying a repetitive sequence.

DNA polymerase loses its place among the FMR1 triplet repeats and goes back to recopy what it already just copied.

This is like getting lost in a video and watch the same part over and over.

But since DNA polymerase is making copies, the effect is an increase, or expansion, of the number of repeats.

The normal number of CGG triplets is 5-44.

Alleles with 45 to 54 CGG repeats are called intermediate expansion alleles and they don’t cause any symptoms.

Alleles with 55 to 200 CGGs are called premutation alleles, and they can cause some mild symptoms.

Finally if an allele has over 200 CGGs, then it’s considered a full fragile X syndrome mutation and can make the chromosome take on its distinctive look.

Alleles can tend to get longer and longer as DNA polymerase becomes more and more unstable copying the longer stretches of repeats, so an intermediate expansion allele can become a premutation allele, and a premutation allele can expand to become a full fragile X syndrome mutation.

The repeat expansion attracts a DNA methylase enzyme to the site and causes the cytosines in the CGG repeats to become methylated.